{"name":"Dong-A Pharmaceutical Co., Ltd.","slug":"dong-a-pharmaceutical-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":3,"colorKey":"oncology","drugs":[{"name":"DA-8159 (Udenafil)","genericName":"DA-8159 (Udenafil)","slug":"da-8159-udenafil","indication":"Erectile dysfunction","status":"phase_3"},{"name":"Exforge®","genericName":"Exforge®","slug":"exforge","indication":"Other","status":"marketed"},{"name":"r-hCG","genericName":"r-hCG","slug":"r-hcg","indication":"Induction of ovulation and pregnancy in infertile women who do not ovulate","status":"phase_3"}]}],"pipeline":[{"name":"DA-8159 (Udenafil)","genericName":"DA-8159 (Udenafil)","slug":"da-8159-udenafil","phase":"phase_3","mechanism":"DA-8159 (Udenafil) inhibits phosphodiesterase type 5 (PDE5), increasing cyclic GMP levels to promote smooth muscle relaxation and improve blood flow.","indications":["Erectile dysfunction"],"catalyst":""},{"name":"Exforge®","genericName":"Exforge®","slug":"exforge","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"r-hCG","genericName":"r-hCG","slug":"r-hcg","phase":"phase_3","mechanism":"r-hCG is a recombinant human chorionic gonadotropin used to stimulate ovulation and treat infertility.","indications":["Induction of ovulation and pregnancy in infertile women who do not ovulate"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMijgJBVV95cUxNYk5fUTdiZXJyZXNiS3ZQc1ZYRldqQ1BKQ2tEcVdqRlZ1U0o2dzNLSEwyU2o3czBDVnpKWC1aYnFJMVNUZ0hDZFRpS2trZGpzUGRJcXltYXoxYWdaLXhzems0VG1ObS1sRzdmUmJ1OFpnSHVwcXpCQXlvdVcxcjJOTWlVTHllcFZRWWItWGJneXI3cGdVb3lXS0RRRktkS0xYMGNqcTY2eXRWTHBTM0NrTGJvRjN6a2ctZWlKTzQyZFZMNWlTWDU1SzZINjh4bVdOVkUxMHhhSjAzX2QxZWMxUDM3MUxSbXVmdkJ2aFhZWGRKbU5IR19kVTN2WVJOSTZkOHpRWWdoVnFFTnNhaGc?oc=5","date":"2026-04-07","type":"trial","source":"Barchart.com","summary":"Hepatitis B Virus Infection Clinical Trial Pipeline Gains Momentum: 80+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight - Barchart.com","headline":"Hepatitis B Virus Infection Clinical Trial Pipeline Gains Momentum: 80+ Companies Lead the Charge in Pioneering New Trea","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxQWkpvT1pGOEZIN0RGUzBYSnIySUVXZ1ZwSktrM3RIZVRTMTJzMHB4QnhSb3JKUTBaTDhTS2lNRWdrLVBJY0lWVG84NzVKZHBSWUZER0NKWVhpbnlucjJxMzVDbnc0ZGRUbmk0VHM3aEZOZ1RzSDZLaUItZEZBb0V4ddIBlAFBVV95cUxQb0lDODZPemhRVkhZWHd2bXBMSVZQYXp6Ukx0TXAxTGZCb2Zmb3VoOExEbjdzYlRsUTQzT3VTT3BpQWNRMWVEeXZUWTJ1MG1fUlBBczFWVFdIQ3N0ZlpvLS1vQXdPUFo4dnUwSDlGRTVSR2FNa3RsdjFSUWl6eldFbUZNRGxVRzV3c1U1Qk9wVjN0RVBU?oc=5","date":"2026-04-06","type":"pipeline","source":"Chosunbiz","summary":"Korea pharma shifts to external hires as price cuts push global R&D - CHOSUNBIZ - Chosunbiz","headline":"Korea pharma shifts to external hires as price cuts push global R&D - CHOSUNBIZ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxQb0lDODZPemhRVkhZWHd2bXBMSVZQYXp6Ukx0TXAxTGZCb2Zmb3VoOExEbjdzYlRsUTQzT3VTT3BpQWNRMWVEeXZUWTJ1MG1fUlBBczFWVFdIQ3N0ZlpvLS1vQXdPUFo4dnUwSDlGRTVSR2FNa3RsdjFSUWl6eldFbUZNRGxVRzV3c1U1Qk9wVjN0RVBU0gGUAUFVX3lxTFBvSUM4Nk96aFFWSFlYd3ZtcExJVlBhenpSTHRNcDFMZkJvZmZvdWg4TERuN3NiVGxRNDNPdVNPcGlBY1ExZUR5dlRZMnUwbV9SUEFzMVZUV0hDc3RmWm8tLW9Bd09QWjh2dTBIOUZFNVJHYU1rdGx2MVJRaXp6V0VtRk1EbFVHNXdzVTVCT3BWM3RFUFQ?oc=5","date":"2026-04-06","type":"pipeline","source":"Chosunbiz","summary":"Korea pharma shifts to external hires to power R&D and global expansion - CHOSUNBIZ - Chosunbiz","headline":"Korea pharma shifts to external hires to power R&D and global expansion - CHOSUNBIZ","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-01-28","type":"pipeline","source":"simplywall.st","summary":"Subdued Growth No Barrier To Dong-A ST Co., Ltd.'s (KRX:170900) Price - simplywall.st","headline":"Subdued Growth No Barrier To Dong-A ST Co., Ltd.'s (KRX:170900) Price","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxOVlNJQ2ttSjhmZFdtcGstdUVRaFdnVUFWbFJmeThBWF9Ma2tJR2pkTE1FV3BTNUJfZm9wOXJWd0lwMjlvbVNUSXJyS0kwS2ZOT2xrS196bUpfVDRMa2E4b0pTQmxDaUc4ek1BOUlINGpHRHgzcm9OQlFUVzhTZ3o1NmZBd3VSanBHUUtTU0NMa2MzZlZnOVVERU5oYnVKdmxIcUtscXJ5WkRtMUZHcl8wdXRNcTZvN0t6ckNMbW1R?oc=5","date":"2025-09-15","type":"deal","source":"ir.ocugen.com","summary":"Ocugen, Inc. and Kwangdong Pharmaceutical Co., Ltd. Complete License Agreement of OCU400 Modifier Gene Therapy for Retinitis Pigmentosa in Korea - ir.ocugen.com","headline":"Ocugen, Inc. and Kwangdong Pharmaceutical Co., Ltd. Complete License Agreement of OCU400 Modifier Gene Therapy for Retin","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE5oQ0pfX2dNLUNtQWhCWlpRYUdpQmUxWnAtQ2F2UnRpSWU1SEMzSzBPYUpUWVpaYXdjYTRzZ2dSM0hJN3U0Tk1hc3BZTHZ0N01YWFlnTF9DbnhfemI0cHdsRHBZWnRnOENLZjg1RkxB0gFyQVVfeXFMT0lVejhsTHlmWm9rZ3dQb1NTUkY2QUFMc2JnZTdGYjkxWVJLbDJkd3EwUkRXN1Q3NzVzaVhBQ1J5SF8ybm4yY1JyN24wb2pWY2JoVmtVNkI4RkhTY0xnZG9RQjJxcGNrZXVadlVJSnV3ajd3?oc=5","date":"2025-08-26","type":"pipeline","source":"koreabiomed.com","summary":"Dong-A ST speeds up developing new drugs utilizing AI - koreabiomed.com","headline":"Dong-A ST speeds up developing new drugs utilizing AI","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidkFVX3lxTE9wU0d2eDIycC1KZHBRRTh6Yjd2RWFfX3pyWklhb1hfa2M3ekplWHd0Z0dVZU9NcjNCZXl6NGRJd0VhSHdxODZwTHZGWlgxWDViQ0NFN1hoSmxIWDZabWhxZVRvLVpTY3V1cmJNZmR4XzdSQjRxTFE?oc=5","date":"2025-08-01","type":"pipeline","source":"KED Global","summary":"Korea's pharmacies emerge as K-beauty destinations for tourists - KED Global","headline":"Korea's pharmacies emerge as K-beauty destinations for tourists","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiS0FVX3lxTE10ZS1mUUdVYm0xVzMwNjNKNU4yaXMyNkxMNlJYSFFyU09TOFNteDdrT2FIdnZtU3lWc3hxNEdXczFnQ2NJTkFmVXh1Zw?oc=5","date":"2025-05-17","type":"pipeline","source":"매일경제","summary":"Hello, MK Pharmacy readers. How is your weekend going.I recently suffered from a sore throat for a f.. - 매일경제","headline":"Hello, MK Pharmacy readers. How is your weekend going.I recently suffered from a sore throat for a f.. - 매일경제","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxONVg3eUJKbHRPdDh4QkpUQzFfbHNsdUFwelZ6SW1CelVVdnQ0emczU0w4LUUwRVlaTUFvcmJxdGZ6NFgtank5bnFhaUlhVnRSRG5iSnVXYmxJMWhrcWNYTjM4Q2M1MUFYaFRRNndjeHByZ2tPUHlmM3RWQk9TcW51bUtkam84RjFEbnJyT1I3ZzRkb3EtZlBlT3RFRU5IdDRJU2I2QTUxVDNmdzVUS3Zsdk1VVUNTZw?oc=5","date":"2024-10-29","type":"pipeline","source":"NutraIngredients.com","summary":"South Korea’s Dong-A Pharma targets SEA markets with kids, beauty supplement range - NutraIngredients.com","headline":"South Korea’s Dong-A Pharma targets SEA markets with kids, beauty supplement range","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizgFBVV95cUxPV3dIN2F0dDdTb3ljZTNSMnFoZ0VDNGgzbFJrSU1LRVgzZmx1dVFZcFFLbUIxaTJHVjJwa2FualVLVEdUbjI1Zm5fRFdQXzZMNS00eGNBTDV0ZGplTlhZdUJTZUllZDBPSEVHaEZyZFVpQzNITnRqcE51RmI0cG51eTBIY2txMlZYZ1F5NVZXcURIX19leEZzM3VDMWtPTVA4eVpHRVdJS3hYNkU1LXpqS3RJUm0tWE5xMm5XTzl2ajZ4OG9iUjBkUU5SeDZyUQ?oc=5","date":"2024-10-11","type":"regulatory","source":"Business Wire","summary":"US FDA Approves Dong-A ST’s IMULDOSA™ (ustekinumab-srlf), a Biosimilar to STELARA® - Business Wire","headline":"US FDA Approves Dong-A ST’s IMULDOSA™ (ustekinumab-srlf), a Biosimilar to STELARA®","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTFAyMl8zNkRsekdhcW9tM3g0Wk9XSjRxVlIyVThaMHlrTHVvQVpfZEJsSGNNRXB1UXFJTEVOS3oyXzZDeHFocUtDc3FNd09abzdQWTh0V3J5RVhiQjVpUEJVMHB2QnB2UXlmSC1RbHRn?oc=5","date":"2022-12-23","type":"pipeline","source":"KED Global","summary":"Dong-A ST incorporates NeuroBo as subsidiary - KED Global","headline":"Dong-A ST incorporates NeuroBo as subsidiary","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxOZHFTRnRtVk92LUtDZEhFZGxMcmdHaXVRUDg5MFFSRVB1dndLR1JkalhSUzQ1OENKaE5hWFp0TldHWi12NXhjY1BzelpINmZ3X0F0RGItQmp1SWNtbG1UWEQ2UDFOektESjJLXzBNazhPbG5pSy1JMjU4N3A2UmM5YTBDenExU3BEOTUtaWRYR3hNRHlJZWdSNFdLanJiNkFIekdlQktoQkZLNnJiaHQxZVdEQXVsaWVzV19B?oc=5","date":"2010-05-10","type":"pipeline","source":"GSK","summary":"GSK extends presence in Asia with new strategic alliance in South Korea - GSK","headline":"GSK extends presence in Asia with new strategic alliance in South Korea","sentiment":"neutral"}],"patents":[],"drugCount":3,"phaseCounts":{"phase_3":2,"marketed":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}